Gagan Singh Malhi, DO
Family Practice · Orinda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · Hackensack Meridian Health Medical Group - Primary Care PC
Hospitals listed: Bayshore Medical Center · Jersey Shore University Medical Center · Ocean University Medical Center · Riverview Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Malhi’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- New Jersey 25MB11949600Doctor of Osteopathic Medicine · since 2023 · expires 2027-06-30Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Bayshore Medical CenterHolmdel, NJAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Hackensack Meridian Health, which runs 13 hospitalsPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
- Jersey Shore University Medical CenterNeptune, NJAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Hackensack Meridian Health, which runs 13 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.36 (0.97 to 1.76) · 16,075 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 15.8 (12.7 to 19.5) · 242 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 131.68 (99.19 to 164.17) · 270 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.187, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.338, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.273, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.213, Oct 2024 – Sep 2025
- Ocean Medical CenterBrick, NJAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Hackensack Meridian Health, which runs 13 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.576, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.139, Oct 2024 – Sep 2025
- Riverview Medical CenterRed Bank, NJAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Hackensack Meridian Health, which runs 13 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.169, Oct 2024 – Sep 2025
See every measure and the patient survey for Bayshore Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.86 (0 to 1.85) · 890 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.51 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 136.63 (81.6 to 191.67) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.8 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 339 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 722 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.1 · 105 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,350 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,416 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 5,492 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.08 (0.9 to 5.25) · 911 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.3 to 3.39) · 854 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.12 (0.89 to 19.35) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.78 (2.54 to 11.01) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.76) · 4,806 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.595 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.76 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.832 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 120 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 372 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.6 · 120 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11.3 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.9 · 767 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 752 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.3) · 167 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 327 cases | No different | Jan 2024 – Dec 2024 |
What patients said (832 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Jersey Shore University Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.36 (0.97 to 1.76) · 16,075 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 15.8 (12.7 to 19.5) · 242 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 131.68 (99.19 to 164.17) · 270 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.338 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.273 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.213 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.62 (0 to 1.37) · 3,079 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.85 to 1.25) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.3 · 451 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 432 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 1,348 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 1,017 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 691 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 6,607 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0.03 to 0.34) · 17,460 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.08 to 0.4) · 18,371 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.5 (1.08 to 3.92) · 5,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.95 (0 to 2.1) · 2,098 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.21 (2.16 to 4.26) · 5,002 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.31 (2.78 to 9.84) · 2,134 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (2.42 to 7.9) · 2,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.37 (1.05 to 3.7) · 903 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 121 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.155 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.9 · 637 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 1,546 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.3 · 693 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.8 · 1,560 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6 · 1,038 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.6 · 1,027 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.8 to 5.8) · 242 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 125 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 373 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 256 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.9 to 19.1) · 469 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,064 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,231 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Ocean Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.576 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.41 to 2.01) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.74 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.94 (98.33 to 195.54) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.8 · 368 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 340 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 976 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 1,041 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 360 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 4,677 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.35) · 12,398 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.35) · 12,506 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (1.04 to 4.64) · 2,076 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.38) · 466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.82 (1.42 to 4.22) · 1,921 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (2.25 to 15.1) · 467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.91 (3.32 to 10.5) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.43 (0.05 to 2.81) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.2 to 1.19) · 11,362 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 31 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.515 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.909 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 265 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 1,147 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2.4 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.1 · 1,099 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17 · 1,078 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 1,167 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.8 to 7.4) · 257 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (9 to 14.7) · 257 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.5 to 16.3) · 365 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 940 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,391 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Riverview Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.72 (0 to 1.62) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.76 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.35 (108.44 to 216.27) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 561 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 588 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.2 · 148 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,831 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.36) · 7,610 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.12 to 0.5) · 7,859 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.6 (2.61 to 6.58) · 1,480 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.94 (0.29 to 3.59) · 524 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.48 (0.99 to 3.98) · 1,345 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (2.6 to 17.67) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7 (3.18 to 10.83) · 503 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.13 to 3.02) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,857 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.593 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.386 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.623 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 106 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 551 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7 · 120 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2 · 621 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.9 · 597 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 519 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3 to 7.1) · 88 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.7 (9.1 to 17.4) · 88 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 125 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.4) · 535 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,073 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,396 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$47,480
Medicare paid this office $47,480 for 261 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 125 | $18,736 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $7,512 | $137 |
| Short return visit (20+ min) | 48 | $3,630 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,835 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,225 | $97 |
See all 12 services
| Return visit (30+ min) | 125 | $18,736 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $7,512 | $137 |
| Short return visit (20+ min) | 48 | $3,630 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,835 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,225 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,495 | $39 |
| Influenza vaccine split virus, preservative free | 18 | $1,473 | $82 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,036 | $80 |
| New patient visit (30+ min) | 11 | $696 | $63 |
| Administration of influenza virus vaccine | 20 | $684 | $34 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 26 | $326 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $121 | $11 |
Who their Medicare patients are
261 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 9% · Women 66% · Also on Medicaid 5% · Health risk score 1.38. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 72% · Coronary heart disease 35% · Diabetes 34% · Depression 29% · Chronic kidney disease 24% · Atrial fibrillation 22% · Heart failure 21% · COPD 21% · Cancer 18% · Stroke 18% · Dementia 9%.
The office billed $193,695, Medicare allowed $61,396 and paid $47,480; for 599 services of 34 kinds; $2,207 of it was for drugs given in the office and $45,273 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 261 | 599 | 73 | 1.38 | $193,695 | $47,480 |
| 2023 | 41 | 54 | 71 | 1.21 | $18,915 | $4,665 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 19 | $2,099 | $105 |
Drugs they prescribed that Part D paid
$147,920
Pharmacies billed $147,920 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (14 of 1,352) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,182 generic and fewer than 11 brand-name prescriptions · $147,920 in drug cost · 83 antibiotic prescriptions to 67 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 17 | $27,509 | $1,618 |
| Mounjaro | 27 | $24,919 | $923 |
| Eliquis | 14 | $12,813 | $915 |
| Ozempic | 14 | $12,327 | $881 |
| Rosuvastatin | 66 | $2,195 | $33 |
See all 35 drugs
| Jardiance | 17 | $27,509 | $1,618 |
| Mounjaro | 27 | $24,919 | $923 |
| Eliquis | 14 | $12,813 | $915 |
| Ozempic | 14 | $12,327 | $881 |
| Rosuvastatin | 66 | $2,195 | $33 |
| Atorvastatin | 53 | $708 | $13 |
| Levothyroxine | 56 | $701 | $13 |
| Pantoprazole | 40 | $483 | $12 |
| Alprazolam | 80 | $417 | $5 |
| Bupropion Xl | 18 | $406 | $23 |
| Albuterol Sulfate Hfa | 13 | $329 | $25 |
| Valsartan | 18 | $277 | $15 |
| Amlodipine Besylate | 54 | $270 | $5 |
| Metoprolol | 25 | $250 | $10 |
| Losartan | 32 | $224 | $7 |
| Zolpidem | 17 | $202 | $12 |
| Nitrofurantoin Mono-Macro | 18 | $177 | $10 |
| Levetiracetam | 13 | $165 | $13 |
| Metformin | 25 | $152 | $6 |
| Fluticasone Propionate | 17 | $151 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $148 | $13 |
| Simvastatin | 17 | $131 | $8 |
| Carvedilol | 16 | $129 | $8 |
| Methylprednisolone | 18 | $123 | $7 |
| Amoxicillin-Clavulanate Potass | 19 | $122 | $6 |
| Fluoxetine | 12 | $115 | $10 |
| Ketoconazole | 17 | $113 | $7 |
| Azithromycin | 15 | $79 | $5 |
| Hydrochlorothiazide | 20 | $70 | $4 |
| Mupirocin | 13 | $70 | $5 |
| Lisinopril | 11 | $67 | $6 |
| Doxycycline Hyclate | 11 | $64 | $6 |
| Naproxen | 14 | $59 | $4 |
| Metformin Hcl Er | 12 | $52 | $4 |
| Omeprazole | 16 | $49 | $3 |
Year by year
| 2024 | 1,352 | 259 | 1% (14) | None | $147,920 |
| 2023 | 122 | 75 | None | None | $6,099 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Azithromycin | 12 | $61 | $5 |
Money from drug and device companies
$1,130 in 2025
| 2025 | 9 | 58 | None | $1,130 |
| 2024 | 10 | 51 | None | $1,235 |
| 2023 | 5 | 12 | None | $288 |
| 2022 | 2 | 4 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $356 | 7 payments
|
| Novo Nordisk | Wegovy | $305 | 14 payments
|
| Abbvie | Vraylar | $216 | 18 payments
|
| Amgen | Krystexxa | $77 | 5 payments
|
| Pfizer | Nurtec Odt | $49 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $46 | 3 payments
|
See all 55 published payments
| GlaxoSmithKline | Meals · 2025-12-02 | Shingrix | $16 |
| Abbvie | Meals · 2025-12-01 | Vraylar | $4 |
| Exact Sciences | Meals · 2025-11-25 | Cologuard Collection Kit | $15 |
| Abbvie | Meals · 2025-11-21 | Vraylar | $15 |
| Amgen | Meals · 2025-11-11 | Krystexxa | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-03 | Breztri | $16 |
| Novo Nordisk | Meals · 2025-10-29 | Wegovy | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-21 | Jardiance | $15 |
| Abbvie | Meals · 2025-10-17 | Ubrelvy | $18 |
| Novo Nordisk | Meals · 2025-10-14 | Wegovy | $119 |
| Abbvie | Meals · 2025-10-08 | Vraylar | $16 |
| Novo Nordisk | Meals · 2025-10-01 | None | $14 |
| Abbvie | Meals · 2025-09-25 | Vraylar | $12 |
| Novo Nordisk | Meals · 2025-09-24 | Wegovy | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-17 | Breztri | $130 |
| Abbvie | Meals · 2025-09-11 | Ubrelvy | $18 |
| Amgen | Meals · 2025-08-27 | Krystexxa | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | Breztri | $32 |
| Novo Nordisk | Meals · 2025-08-07 | Wegovy | $14 |
| Abbvie | Meals · 2025-07-16 | Vraylar | $12 |
| Novo Nordisk | Meals · 2025-07-15 | Wegovy | $12 |
| Novo Nordisk | Meals · 2025-07-09 | Rybelsus | $14 |
| Abbvie | Meals · 2025-07-08 | Qulipta | $22 |
| Amgen | Meals · 2025-06-10 | Krystexxa | $14 |
| Lilly USA | Meals · 2025-06-05 | Mounjaro | $17 |
| Novo Nordisk | Meals · 2025-06-05 | Wegovy | $13 |
| Abbvie | Meals · 2025-06-04 | Vraylar | $5 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-03 | Breztri | $17 |
| Lilly USA | Meals · 2025-05-13 | Mounjaro | $17 |
| Pfizer | Meals · 2025-05-12 | Nurtec Odt | $18 |
| Abbvie | Meals · 2025-05-08 | Vraylar | $13 |
| Novo Nordisk | Meals · 2025-05-07 | Wegovy | $15 |
| Abbvie | Meals · 2025-04-23 | Vraylar | $3 |
| Novo Nordisk | Meals · 2025-04-16 | Wegovy | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-14 | Breztri | $18 |
| Abbvie | Meals · 2025-04-11 | Vraylar | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-02 | Breztri | $125 |
| Abbvie | Meals · 2025-04-01 | Vraylar | $4 |
| Amgen | Meals · 2025-03-24 | Krystexxa | $15 |
| Exact Sciences | Meals · 2025-03-13 | Cologuard Collection Kit | $15 |
| Novo Nordisk | Meals · 2025-03-11 | Wegovy | $11 |
| Novo Nordisk | Meals · 2025-03-10 | Ozempic | $16 |
| Abbvie | Meals · 2025-03-06 | Ubrelvy | $17 |
| Pfizer | Meals · 2025-03-05 | Nurtec Odt | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-18 | Airsupra | $18 |
| Pfizer | Meals · 2025-02-11 | Prevnar 20 | $14 |
| Novo Nordisk | Meals · 2025-02-04 | Wegovy | $17 |
| Exact Sciences | Meals · 2025-01-28 | Cologuard Collection Kit | $16 |
| Abbvie | Meals · 2025-01-27 | Vraylar | $8 |
| Amgen | Meals · 2025-01-27 | Krystexxa | $19 |
| Abbvie | Meals · 2025-01-15 | Vraylar | $10 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $14 |
| Abbvie | Meals · 2025-01-08 | Ubrelvy | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-06 | Jardiance | $16 |
| Abbvie | Meals · 2025-01-02 | Vraylar | $10 |
See earlier years (2024, 2023, 2022)
2024: $1,235
| Abbvie | Vraylar | $369 | 15 payments
|
| Amgen | Krystexxa | $333 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $191 | 6 payments
|
| Novo Nordisk | Wegovy | $175 | 12 payments
|
| Pfizer | Nurtec Odt | $73 | 5 payments
|
| GlaxoSmithKline | Shingrix | $31 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
| Lilly USA | Jardiance | $16 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $13 | 1 payment
|
2023: $288
| AstraZeneca Pharmaceuticals LP | Farxiga | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $57 | 4 payments
|
| Novo Nordisk | Wegovy | $46 | 3 payments
|
| Abbvie | Vraylar | $45 | 3 payments
|
| Pfizer | Nurtec Odt | $14 | 1 payment
|
2022: $56
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $42 | 3 payments
|
| Sanofi-Aventis U.S. | Synvisc-One | $13 | 1 payment
|
Professional record
- NPI
- 1366070807
- Group
- Sutter Bay Medical Foundation · Hackensack Meridian Health Medical Group - Primary Care PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 49 Poplar Ln, Holmdel, NJ, 07733
- NPI first listed
- 2020-03-30
- NPI last updated
- 2025-12-24
- NPI record certified
- 2025-12-24
This is when the NPI record was last certified, not a medical board exam.